Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma.

Mo, Dun-Chang; Huang, Jian-Feng; Luo, Peng-Hui; Chen, Long; Huang, Shang-Xiao

Mo, Dun-Chang; Huang, Jian-Feng; Luo, Peng-Hui; Chen, Long; Huang, Shang-Xiao.

Afiliação

Mo DC; Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530000, China. Electronic address: modunchang2018@163.com.
Huang JF; Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
Luo PH; Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
Chen L; Otorhinolaryngology Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
Huang SX; Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.

Lancet Oncol ; 24(1): e7, 2023 01.

Article em En | MEDLINE | ID: mdl-36603930

Assuntos

Melanoma; Neoplasias Cutâneas; Humanos; Melanoma/tratamento farmacológico; Melanoma/cirurgia; Anticorpos Monoclonais Humanizados/efeitos adversos; Neoplasias Cutâneas/tratamento farmacológico; Neoplasias Cutâneas/cirurgia; Estadiamento de Neoplasias

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google